DOI QR코드

DOI QR Code

Self-expandable metallic stent-induced esophagorespiratory fistulas in patients with advanced esophageal cancer

  • Iatagan R. Josino (Department of Gastroenterology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo) ;
  • Bruno C. Martins (Department of Gastroenterology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo) ;
  • Andressa A. Machado (Department of Gastroenterology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo) ;
  • Gustavo R. de A. Lima (Department of Gastroenterology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo) ;
  • Martin A. C. Cordero (Department of Gastroenterology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo) ;
  • Amanda A. M. Pombo (Department of Gastroenterology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo) ;
  • Rubens A. A. Sallum (Department of Gastroenterology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo) ;
  • Ulysses Ribeiro Jr (Department of Gastroenterology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo) ;
  • Todd H. Baron (Division of Gastroenterology and Hepatology, University of North Carolina) ;
  • Fauze Maluf-Filho (Department of Gastroenterology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo)
  • 투고 : 2022.11.04
  • 심사 : 2023.03.10
  • 발행 : 2023.11.30

초록

Background/Aims: Self-expandable metallic stents (SEMSs) are widely adopted for the palliation of dysphagia in patients with malignant esophageal strictures. An important adverse event is the development of SEMS-induced esophagorespiratory fistulas (SEMS-ERFs). This study aimed to assess the risk factors related to the development of SEMS-ERF after SEMS placement in patients with esophageal cancer. Methods: This retrospective study was performed at the Instituto do Cancer do Estado de São Paulo. All patients with malignant esophageal strictures who underwent esophageal SEMS placement between 2009 and 2019 were included in the study. Results: Of the 335 patients, 37 (11.0%) developed SEMS-ERF, with a median time of 129 days after SEMS placement. Stent flare of 28 mm (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.15-5.51; p=0.02) and post-stent chemotherapy (HR, 2.0; 95% CI, 1.01-4.00; p=0.05) were associated with an increased risk of developing SEMS-ERF, while lower-third tumors were a protective factor (HR, 0.5; 95% CI, 0.26-0.85; p=0.01). No difference was observed in overall survival. Conclusions: The incidence of SEMS-ERFs was 11%, with a median time of 129 days after SEMS placement. Post-stent chemotherapy and a 28 mm stent flare were associated with a higher risk of SEMS-ERF.

키워드

과제정보

The authors would like to thank all nurses, doctors, and other employees of the GI Endoscopy Department at the Instituto do Cancer do Estado de Sao Paulo. It requires great individual commitment to achieve great teamwork. We also appreciate all other professionals involved in the care of patients included in this study for their indirect contribution.

참고문헌

  1. Napier KJ, Scheerer M, Misra S. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 2014;6:112-120.
  2. Parker RK, White RE, Topazian M, et al. Stents for proximal esophageal cancer: a case-control study. Gastrointest Endosc 2011;73:1098-1105.
  3. Medeiros VS, Martins BC, Lenz L, et al. Adverse events of self-expandable esophageal metallic stents in patients with long-term survival from advanced malignant disease. Gastrointest Endosc 2017;86:299-306.
  4. Homann N, Noftz MR, Klingenberg-Noftz RD, et al. Delayed complications after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci 2008;53:334-340.
  5. Lenz CJ, Bick BL, Katzka D, et al. Esophagorespiratory fistulas: survival and outcomes of treatment. J Clin Gastroenterol 2018;52:131-136.
  6. Bick BL, Song LM, Buttar NS, et al. Stent-associated esophagorespiratory fistulas: incidence and risk factors. Gastrointest Endosc 2013;77:181-189.
  7. Nagaraja V, Cox MR, Eslick GD. Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis. J Gastrointest Oncol 2014;5:119-126.
  8. Sreedharan A, Harris K, Crellin A, et al. Interventions for dysphagia in oesophageal cancers. Cochrane Database Syst Rev 2009;(4):CD005048.
  9. Raijman I, Siddique I, Ajani J, et al. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc 1998;48:172-179.
  10. Chen YH, Li SH, Chiu YC, et al. Comparative study of esophageal stent and feeding gastrostomy/jejunostomy for tracheoesophageal fistula caused by esophageal squamous cell carcinoma. PLoS One 2012;7:e42766.
  11. Na HK, Song HY, Kim JH, et al. How to design the optimal self-expandable oesophageal metallic stents: 22 years of experience in 645 patients with malignant strictures. Eur Radiol 2013;23:786-796.
  12. Ross WA, Alkassab F, Lynch PM, et al. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc 2007;65:70-76.
  13. Ribeiro MS, da Costa Martins B, Simas de Lima M, et al. Self-expandable metal stent for malignant esophagorespiratory fistula: predictive factors associated with clinical failure. Gastrointest Endosc 2018;87:390-396.
  14. Bethge N, Sommer A, Gross U, et al. Human tissue responses to metal stents implanted in vivo for the palliation of malignant stenoses. Gastrointest Endosc 1996;43:596-602.
  15. Javed A, Pal S, Dash NR, et al. Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial. J Gastrointest Cancer 2012;43:63-69.
  16. Park JY, Shin JH, Song HY, et al. Airway complications after covered stent placement for malignant esophageal stricture: special reference to radiation therapy. AJR Am J Roentgenol 2012;198:453-459.
  17. Kim KY, Tsauo J, Song HY, et al. Self-expandable metallic stent placement for the palliation of esophageal cancer. J Korean Med Sci 2017;32:1062-1071.
  18. Nishimura Y, Nagata K, Katano S, et al. Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol Biol Phys 2003;56:1327-1332.
  19. Kinsman KJ, DeGregorio BT, Katon RM, et al. Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. Gastrointest Endosc 1996;43:196-203.
  20. Spaander MC, Baron TH, Siersema PD, et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2016;48:939-948.
  21. Machado AA, da Costa Martins B, Lima GR, et al. Impact of radiotherapy (RT) on adverse events of self-expanding metallic stents (SEMS) in patients with esophageal cancer. Gastrointest Endosc 2020;91:AB149.
  22. Homs MY, Hansen BE, van Blankenstein M, et al. Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma. Eur J Gastroenterol Hepatol 2004;16:163-170.